Table 1.
Characteristics | Value | |
Age (years) | ||
|
Mean (SD) | 57.2 (11.08) |
|
Median (range) | 57 (27-78) |
|
Q1-Q3 | 50-65 |
Gender, n (%) | ||
|
Male | 85 (42.5) |
|
Female | 115 (57.5) |
Diagnosis, n (%) | ||
|
Breast cancer | 115 (57.5) |
|
Prostate cancer | 85 (42.5) |
Treatment setting, n (%) | ||
|
Curative | 169 (84.5) |
|
Palliative | 31 (15.5) |
T status, n (%) | ||
|
is | 4 (2.0) |
|
1 | 88 (44.0) |
|
2 | 65 (32.5) |
3 | 36 (18.0) | |
|
4 | 4 (2.0) |
|
X | 1 (0.5) |
|
Unknown | 2 (1.0) |
N status, n (%) | ||
|
0 | 132 (66.0) |
|
+ | 19 (9.5) |
|
1 | 38 (19.0) |
|
2 | 4 (2.0) |
|
3 | 4 (2.0) |
|
X | 3 (1.5) |
M status, n (%) | ||
|
0 | 159 (79.5) |
|
1 | 34 (17.0) |
|
X | 7 (3.5) |
Initial Karnofsky performance index, n (%) | ||
|
60 | 3 (1.5) |
|
70 | 19 (9.5) |
|
80 | 43 (21.5) |
|
90 | 68 (34.0) |
|
100 | 67 (33.5) |
Previous radiotherapy, n (%) | ||
|
No | 144 (72.0) |
|
Yes | 56 (28.0) |
Tumor stagea, n (%) | ||
|
Early | 102 (51.0) |
|
Advanced | 98 (49.0) |
aEarly tumor stage: Tis/1/2, N0, M0; advanced tumor stage: T3 or above, N1 or above, M1.